Near-poverty adults with elevated liver enzymes carry a metabolic burden that higher-income adults don't. 73.2% of near-poverty adults with elevated ALT also have obesity or prediabetes/diabetes, compared to 64.0% among higher-income adults. That 9-point gap represents a compounding of conditions that makes liver disease harder to treat, harder to catch early, and more likely to progress.

The Income Gradient in Metabolic Overlap

The relationship between income and comorbidity burden among adults with elevated ALT isn't linear. It peaks in the near-poverty band, not at the bottom.

Near-poverty adults show the highest obesity rate among those with elevated ALT at 59.5%, compared to 45.5% in the below-poverty group and 50.6% among higher-income adults. Their prediabetes and diabetes rate of 54.9% also leads every other income group. When both conditions are counted together, 73.2% of near-poverty adults with elevated ALT carry at least one of them.

For clinicians and health systems, this matters because elevated ALT in the context of obesity and dysglycemia is a well-established pathway toward nonalcoholic fatty liver disease and cirrhosis. Adults in this income band are carrying the full metabolic stack, and they're doing so at rates that exceed even the poorest adults in this dataset.

Why the Near-Poverty Group Stands Out

The below-poverty group, despite having lower incomes, shows lower comorbidity overlap: 62.1% have obesity or prediabetes/diabetes, compared to 73.2% in the near-poverty group. That 11-point difference within the low-income population is one of the more counterintuitive findings in the data.

Near-poverty adults often sit just above the eligibility thresholds for Medicaid and food assistance programs, while remaining far below the income levels that provide consistent access to preventive care, gym memberships, or diet quality. The result, visible in this data, is a population that has absorbed the metabolic consequences of economic precarity without the safety net that catches those below the poverty line.

The 54.9% prediabetes/diabetes rate in this group is particularly striking. Among higher-income adults with elevated ALT, that figure drops to 38.7%. A 16-point gap in dysglycemia prevalence, within a population already selected for liver stress, suggests that near-poverty adults are managing multiple metabolic conditions simultaneously at rates that should concern anyone tracking downstream liver disease burden.

Race, Education, and Enzyme Levels Among Non-Drinkers

Alcohol confounds liver enzyme readings, so restricting to non-drinkers isolates metabolic and other contributors. Among non-drinking adults, the variation by race and education is substantial, though many subgroup samples are small enough to treat with caution.

Non-drinking Mexican American adults with less than a 9th grade education had a weighted mean ALT of 31.2, compared to 19.5 for Non-Hispanic White adults at the same education level. That's a 60% difference in mean ALT within the same educational stratum, among people who don't drink. Non-drinking Non-Hispanic White high school graduates, a larger and more stable sample of 59, had a weighted mean ALT of 21.8 and AST of 22.5, both within normal range.

One cell stands out for a different reason: non-drinking Non-Hispanic Black college graduates had a weighted mean ALT of 37.9 and AST of 37.1, based on a sample of 11. The sample is too small to generalize, but the values are elevated enough to flag. ALT readings in that range, even without alcohol as a driver, point toward metabolic or other hepatic stress that warrants attention in future, larger analyses.

Taken across both analyses, the picture is consistent: liver enzyme elevation doesn't distribute evenly across income or demographic lines. Near-poverty adults carry the heaviest combined burden of elevated ALT plus metabolic disease. And among non-drinkers, racial and educational gradients in enzyme levels persist even after removing the most common behavioral confounder.

What the data can't resolve is why near-poverty adults show higher comorbidity rates than the poorest adults, despite having more income. That gap, 73.2% versus 62.1%, is the number that should drive the next round of questions.